Who
Kirti Desai
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Tevogen.
In numbers
- Trades disclosed
- 8
- Buys
- 1
- Sells
- 0
- Bought
- $2,460
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 14 Feb 2024
- Last trade
- 14 Sep 2026
- Last filed
- 16 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Sep 2026filed 16 Sep 2026 | TVGN TevogenBiotechnology | SEC FORM 4 Code A | —750,000 at $0.00 | filing |
| 14 Sep 2026filed 16 Sep 2026 | TVGN TevogenBiotechnology | SEC FORM 4 Code A | —750,000 at $0.00 | filing |
| 10 Jul 2026filed 10 Jul 2026 | TVGN TevogenBiotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 10 Jul 2026filed 10 Jul 2026 | TVGN TevogenBiotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 11 Dec 2025filed 15 Dec 2025 | TVGN TevogenBiotechnology | SEC FORM 4 Code G | —300,000 at $0.00 | filing |
| 27 Jun 2025filed 1 Jul 2025 | TVGN TevogenBiotechnology | SEC FORM 4 Code A | —750,000 at $0.00 | filing |
| 12 Jun 2024filed 13 Jun 2024 | TVGN TevogenBiotechnology | SEC FORM 4 Bought | $2,4603,000 at $0.82 | filing |
| 14 Feb 2024filed 16 Feb 2024 | TVGN TevogenBiotechnology | SEC FORM 4 Code A | —9,696,186 | filing |
News
No headline names them, or the companies they trade most, lately.